Alterations in cardiac and renal biomarkers have been reported in coronavirus disease 19
(COVID-19). We conducted a systematic review and meta-analysis to investigate serum …

Aims Many studies have explored the clinical characteristics of patients with coronavirus
disease (COVID‐19), especially patients with cardiovascular disease. However, associated …

Abstract Background Coronavirus disease‐2019 (COVID‐19) has spread all over the world
and brought extremely huge losses. At present, there is a lack of study to systematically …

Background: This meta-analysis outlines the role of elevated lactate dehydrogenase (LDH)
levels in assessing the severity of coronavirus disease 2019 (COVID-19). Methods: The …

Purpose This meta-analysis aimed to evaluate the prognostic performance of elevated
lactate dehydrogenase (LDH) in patients with COVID-19. Methods A systematic literature …

Background and aims Clinical and laboratory predictors of adverse clinical course and
death in COVID-19 patients urgently need to be identified. So far, the association between …

Abstract Case Series Presentation Eight elderly confirmed SARS-CoV-2 patients who had
severe course of COVID-19 and admitted to ICU expressed high lactate dehydrogenase …

Early identification of severe patients with coronavirus disease 2019 (COVID-19) is very
important for individual treatment. We included 203 patients with COVID-19 by propensity …

Background Patients with coronavirus disease 2019 (COVID-19) and underlying
cardiovascular comorbidities have poor prognoses. Our aim was to identify the impact of …

Background: In this study, we investigated the relationship between serum lactate
dehydrogenase (LDH) level and disease progression and prognosis of patients with COVID …